TO: Audit Committee THROUGH: Matthew Dent FROM: Audit Committee Chair Paul Navazio Director of Finance SUBJECT: Staff Update - I
![Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells - Marx - 2021 - Molecular Oncology - Wiley Online Library Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells - Marx - 2021 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/e0895cb9-dd12-40d6-8a64-e317eb004ac5/mol213060-fig-0005-m.jpg)
Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells - Marx - 2021 - Molecular Oncology - Wiley Online Library
![Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells - Marx - 2021 - Molecular Oncology - Wiley Online Library Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells - Marx - 2021 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/bc64549a-352f-416f-afa1-cb324bd9fcbc/mol213060-fig-0004-m.jpg)